Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with an incidence of 1:3000. Approximately 30% of NF1 patients develop plexiform neurofibromas (PNF) which often cause severe clinical deficits. We studied the growth patterns of 256 plexiform neurofibromas (PNF) by magnetic resonance imaging (MRI) and associated disfigurement and functional deficits to determine whether there are definable growth types of these tumors. Retrospectively, we evaluated MRI scans obtained during 1997 to 2003 of 256 plexiform neurofibromas from 202 patients with NF1. Clinical investigation was carried out at the same time as the MRI scans. We identified three growth patterns: superficial in 59, displacing in 76, and invasive growth in 121 tumors. The majority (52%) of invasive PNF were found in the face, head and neck area. While superficial PNF primarily caused aesthetic problems, displacing PNF led in most cases to aesthetic problems and pain, while invasive PNF led mainly to functional deficits and disfigurement. Our study demonstrates that PNF have different growth patterns that are associated with specific clinical features. Classification of PNF may open new opportunities in clinical management, especially regarding decisions and options associated with surgical intervention.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Huson SM, Harper PS, Compston DAS (1988) Von Recklinghausen neurofibromatosis – a clinical and population study in south-east Wales. Brain 111:1355–1381
Lammert M, Friedman JM, Kluwe L, Mautner VF (2005) Prevalence of neurofibromatosis 1 in German children at elementary school enrolment. Arch Dermatol 141(1):71–74
Tonsgard JH, Kwak SM, Short P, Dachman AH (1988) CT imaging in adults with neurofibromatosis-1. Frequent asymptomatic plexiform lesions. Neurology 50:1755–1760
McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R, Kingston H, Super M, Harris R, Evans DGR (1999) A clinical study of type 1 neurofibromatosis in north west England. J Med Genet 36:197–203
Rasmussen SA, Quanhe Y, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68:1110–1118
Korf BR (1999) Plexiform neurofibroma. Am J Med Genet 89(1):31–37
Friedrich RE, Korf B, Fünsterer C, Mautner VF (2003) Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images. Anticancer Res 23:949–952
Peh WC, Shek TW, Yip DK (1997) Magnetic resonance imaging of subcutaneous diffuse neurofibromas. Br J Radiol 70(839):1180–1183
Jabra AA, Taylor GA (1993) MRI evaluation of superficial soft tissue lesions in children. Pediatr Radiol 23(6):425–428
Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51–57
Friedrich RE, Schmelzle R, Hartmann M, Mautner VF (2005) Subtotal and total resection of superficial plexiform neurofibromas of face and neck: four case reports. J Craniomaxillofac Surg 33(1):55–60
Thakkar SD, Feigen U, Mautner VF (1999) Spinal tumors in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety. Neuroradiology 41:625–629
Woodruf JM, Lourea HP, Louis DN, Scheitauer BW (2000) Neurofibroma. In: Kleihues P, Cavenee WK (eds) World Health Organisation classification of tumors, pathology and genetics of tumors of the nervous system. IARC Press, Lyon, pp 167–168
Acknowledgement
This work was supported by Deutsche Krebsgesellschaft Ma 70-3072.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mautner, V.F., Hartmann, M., Kluwe, L. et al. MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1. Neuroradiology 48, 160–165 (2006). https://doi.org/10.1007/s00234-005-0033-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-005-0033-4